Status:

RECRUITING

Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward

Lead Sponsor:

Nantes University Hospital

Conditions:

Community-acquired Pneumonia

Eligibility:

All Genders

65+ years

Phase:

PHASE3

Brief Summary

Reduce inappropriate antibiotic use is a priority of public health agencies. Community-acquired pneumonia (CAP) is one of the most important indications for antibiotic prescriptions. In the majority ...

Detailed Description

Thus, the goal of the proposed trial is to compare clinical efficacy and safety of two CAP antimicrobial treatments, amoxicillin and amoxicillin/clavulanate, in patients aged 65 years or older and hos...

Eligibility Criteria

No eligibility criteria provided.

Key Trial Info

Start Date :

April 25 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 25 2027

Estimated Enrollment :

326 Patients enrolled

Trial Details

Trial ID

NCT06229288

Start Date

April 25 2024

End Date

May 25 2027

Last Update

January 27 2026

Active Locations (19)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (19 locations)

1

CH Saint-Nazaire

Saint-Nazaire, France, France, 44600

2

CH Saint-Nazaire

Saint-Nazaire, France, France, 44600

3

Chu Angers

Angers, France

4

CHU Angers

Angers, France

Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward | DecenTrialz